| Primary |
| Product Used For Unknown Indication |
68.4% |
| Scan Myocardial Perfusion |
23.9% |
| Cardiac Stress Test |
3.4% |
| Hypertension |
0.7% |
| Chest Pain |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Atrial Fibrillation |
0.3% |
| Exercise Electrocardiogram |
0.2% |
| Cardiac Imaging Procedure |
0.2% |
| Cardiac Disorder |
0.2% |
| Constipation |
0.2% |
| Coronary Artery Disease |
0.2% |
| Hyperlipidaemia |
0.2% |
| Myocardial Ischaemia |
0.2% |
| Blood Cholesterol |
0.1% |
| Muscle Spasms |
0.1% |
| Prophylaxis |
0.1% |
| Acute Myocardial Infarction |
0.1% |
| Asthma |
0.1% |
| Diabetes Mellitus |
0.1% |
|
| Vomiting |
15.5% |
| Injection Site Extravasation |
11.6% |
| Nausea |
9.2% |
| Diarrhoea |
5.5% |
| Cardiac Arrest |
5.3% |
| Unresponsive To Stimuli |
5.3% |
| Tremor |
5.2% |
| Syncope |
4.4% |
| Headache |
4.3% |
| Pain In Extremity |
4.2% |
| Dyspnoea |
3.3% |
| Hypotension |
3.3% |
| Infusion Site Extravasation |
3.3% |
| Hypertension |
3.2% |
| Wheezing |
3.2% |
| Loss Of Consciousness |
2.9% |
| Chest Pain |
2.7% |
| Heart Rate Increased |
2.7% |
| Convulsion |
2.6% |
| Myocardial Infarction |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
63.3% |
| Scan Myocardial Perfusion |
14.8% |
| Cardiac Stress Test |
4.3% |
| Back Pain |
2.9% |
| Chest Pain |
2.4% |
| Atrial Fibrillation |
1.9% |
| Exercise Electrocardiogram |
1.9% |
| Dyspnoea |
1.4% |
| Constipation |
1.0% |
| Diagnostic Procedure |
1.0% |
| Headache |
1.0% |
| Blood Cholesterol |
0.5% |
| Blood Cortisol |
0.5% |
| Drug Hypersensitivity |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Hypertension |
0.5% |
| Ischaemia |
0.5% |
| Myocardial Perfusion Scan |
0.5% |
| Nausea |
0.5% |
| Pain |
0.5% |
|
| Injection Site Extravasation |
25.0% |
| Pain In Extremity |
10.0% |
| Off Label Use |
7.5% |
| Angioedema |
5.0% |
| Infusion Site Pain |
5.0% |
| Injection Site Pain |
5.0% |
| Nausea |
5.0% |
| Retroperitoneal Haemorrhage |
5.0% |
| Vomiting |
5.0% |
| Atrioventricular Block |
2.5% |
| Blood Albumin Decreased |
2.5% |
| Blood Calcium Decreased |
2.5% |
| Bradycardia |
2.5% |
| Drug Ineffective |
2.5% |
| Dyspnoea |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Grand Mal Convulsion |
2.5% |
| Headache |
2.5% |
| Hypoaesthesia |
2.5% |
| No Therapeutic Response |
2.5% |
|
| Concomitant |
| Blood Pressure |
17.6% |
| Chest Pain |
17.6% |
| Antiplatelet Therapy |
11.8% |
| Positron Emission Tomogram |
11.8% |
| Thyroid Disorder |
11.8% |
| Coronary Artery Disease |
5.9% |
| Myocardial Ischaemia |
5.9% |
| Nuclear Magnetic Resonance Imaging |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Scan Myocardial Perfusion |
5.9% |
|
| Dyspnoea |
16.7% |
| Oedema Peripheral |
16.7% |
| Product Quality Issue |
16.7% |
| Radiation Exposure |
16.7% |
| Therapeutic Agent Urine Positive |
16.7% |
| Vomiting |
16.7% |
|
